Finance Minister Nirmala Sitharaman and Bio Pharma Representative Image 
Business

Budget proposes Rs 10,000 cr investment in biopharma over next 5 years

She also proposed interventions in six areas, including manufacturing, strategic and frontier sectors, healthcare and advanced technology.

PTI

NEW DELHI: Finance Minister Nirmala Sitharaman on Sunday proposed Rs 10,000 crore investment in the biopharma sector over the next five years, a move which would give a boost to the country's pharmaceuticals industry.

Biopharmaceuticals, or biologics, are complex medicines manufactured from living organisms, cells, or tissues rather than through chemical synthesis.

She also proposed interventions in six areas, including manufacturing, strategic and frontier sectors, healthcare and advanced technology.

The minister added that semiconductor mission 2.0 will focus on producing equipment and materials designed for full-stack Indian IP (intellectual property).

The India Semiconductor Mission (ISM) is a specialized, autonomous business division within Digital India Corporation under Ministry of Electronics and Information Technology (MeitY), designed to build a sustainable semiconductor and display ecosystem.

Sitharaman also announced support for mineral rich states of Odisha, Kerala, Andhra Pradesh and Tamil Nadu to establish critical mineral facilities.

She added that 'Sabka Saath, Sabka Vikas' is the third Kartavya of the government.

Union Budget 2026: Cancer drugs, overseas travel cheaper; alcohol and income-tax penalties get costlier

Carlos Alcaraz beats Novak Djokovic to become the youngest man to complete a career Grand Slam

Deepam row: Cases registered for remarks against Justice Swaminathan, TN DGP tells SC

HIGHLIGHTS | Union Budget 2026: Rare earth corridor, high-speed rail announced for TN; revised I-T return deadline extended to March 31

Budget lacklustre, disappointing, blind to India's real crises: Cong